Epigraph hemagglutinin vaccine induces broad cross-reactive immunity against swine H3 influenza virus

Abstract

Influenza A virus infection in swine impacts the agricultural industry in addition to its zoonotic potential. Here, we utilize epigraph, a computational algorithm, to design a universal swine H3 influenza vaccine. The epigraph hemagglutinin proteins are delivered using an Adenovirus type 5 vector and are compared to a wild type hemagglutinin and the commercial inactivated vaccine, FluSure. In mice, epigraph vaccination leads to significant cross-reactive antibody and T-cell responses against a diverse panel of swH3 isolates. Epigraph vaccination also reduces weight loss and lung viral titers in mice after challenge with three divergent swH3 viruses. Vaccination studies in swine, the target species for this vaccine, show stronger levels of cross-reactive antibodies and T-cell responses after immunization with the epigraph vaccine compared to the wild type and FluSure vaccines. In both murine and swine models, epigraph vaccination shows superior cross-reactive immunity that should be further investigated as a universal swH3 vaccine.

PhIP-Seq Reveals Autoantibodies for Ubiquitously Expressed Antigens in Viral Myocarditis

“…To establish a virus control system for CVB infections, we performed an experiment to infect groups of BALB/c mice that are susceptible to influenza infection [ 37 , 38 ]. Sera collected from infected or naïve animals on day 21 post-infection were analyzed for their reactivity to COA4 and PIK3AP1, with CVB3 VP1 and KLH as controls.…”

Expanding Mouse-Adapted Yamagata-like Influenza B Viruses in Eggs Enhances In Vivo Lethality in BALB/c Mice

“…Lethality of Phu/13 and FL/4/06 in Mice Prior to Mouse-Adapting Influenza viruses do not typically cause disease in mice. However, lethal challenge strains of influenza are often optimal for vaccine and therapeutics studies [26,29,[32][33][34]. Therefore, mouse-adapting is used to produce a disease model for use in laboratory studies [23,26].…”

“…However, IBVs are not consistently found infecting species outside humans [2,3], which then requires adaptation of the viruses to develop a disease model for in vivo research. Scientists have used serial lung passaging, termed mouse-adapting, of virus to study viral characteristics or to increase pathogenicity of IBVs [22][23][24][25][26] and IAVs [27][28][29] in mice. Mouse-adapted strains are valuable for vaccine and therapeutic research by causing severe infection, which can highlight differences in protection after vaccination or therapeutic delivery.…”

Researchers getting closer to a “universal” flu vaccine

“…Working in pigs, which can serve as mixing vessels for avian, human, and pig strains to swap genome segments, Weaver’s team recently developed a vaccine aimed at protecting North American swine from H3 strains—a diverse influenza A subtype that circulates in both humans and pigs ( 11 ). Pigs vaccinated with a mixture of three synthetic hemagglutinin proteins generated antibodies that protected against 11 of 13 North American H3 swine strains tested.…”